dehydroepiandrosterone has been researched along with quercetin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Awolade, P; Cele, N; Gummidi, L; Kerru, N; Oluwakemi, E; Singh, P | 1 |
| Haines, DC; Hursting, SD; Perkins, SN; Phang, JM; Ward, JM | 1 |
| Eaton, EA; Walle, T; Walle, UK | 1 |
| Nakayama, Y; Sakamoto, H; Satoh, K; Yamamoto, T | 1 |
| Kauffman, FC; Mesía-Vela, S | 1 |
| Alaee, S; Neisy, A; Seghatoleslam, A; Zal, F | 1 |
| Jafari Khorchani, M; Neisy, A; Zal, F | 1 |
| Adetunji, CO; Ayobami, D; Bamidele, O; Femi, A; Mali, PC; Okotie, G; Olaniyan, OT; Olugbenga, E; Oluwaseun, I; Priscilla, B | 1 |
| Abdelazeim, SA; Aly, HF; Shams, SGE; Shehata, NI | 1 |
| Chen, Y; Li, M; Ma, M; Zheng, S | 1 |
| Abo-Zeid, FS; Elfiky, AM; Mahmoud, AA | 1 |
| Chen, K; Du, D; Jiang, H; Liu, L; Liu, Y; Lu, T; Luo, C; Luo, Z; Shan, C | 1 |
2 review(s) available for dehydroepiandrosterone and quercetin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
Topics: Dose-Response Relationship, Drug; Glucuronidase; Glycoproteins; Humans; Molecular Structure; Structure-Activity Relationship | 2020 |
11 other study(ies) available for dehydroepiandrosterone and quercetin
| Article | Year |
|---|---|
Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
Topics: Animals; Anticarcinogenic Agents; Cyclohexenes; Dehydroepiandrosterone; Gene Deletion; Genes, p53; Limonene; Male; Mice; Mice, Inbred C57BL; Neoplasms; Quercetin; Terpenes; Tretinoin | 1995 |
Quercetin, a potent and specific inhibitor of the human P-form phenosulfotransferase.
Topics: Arylsulfotransferase; Dehydroepiandrosterone; Dopamine; Humans; Liver; Molecular Probes; Nitrophenols; Quercetin; Sulfotransferases | 1995 |
Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system.
Topics: Antineoplastic Agents, Hormonal; Cell Division; Colonic Neoplasms; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Fluorouracil; Gene Expression; Gonadal Steroid Hormones; Growth Inhibitors; Humans; Inhibitor of Apoptosis Proteins; Ligands; Microtubule-Associated Proteins; Neoplasm Proteins; Protein Biosynthesis; Proteins; Quercetin; Receptors, Estrogen; Receptors, Progesterone; Steroids; Survivin; Tamoxifen; Telomerase; Testosterone; Thymidylate Synthase; Tumor Cells, Cultured | 2000 |
Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids.
Topics: Animals; Arylsulfotransferase; Dehydroepiandrosterone; Diet; Enzyme Inhibitors; Flavonoids; Genistein; Glucuronosyltransferase; Hymecromone; Inhibitory Concentration 50; Isoflavones; Kaempferols; Liver; Male; Quercetin; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Structure-Activity Relationship; Sulfotransferases | 2003 |
Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERα gene expression in rats with polycystic ovary syndrome (PCOS).
Topics: Animals; Antioxidants; Dehydroepiandrosterone; Disease Models, Animal; Estrogen Receptor alpha; Female; Gene Expression; Glucose Transporter Type 4; Insulin Resistance; Polycystic Ovary Syndrome; Quercetin; Rats; Uterus | 2019 |
The phytoestrogen, quercetin, in serum, uterus and ovary as a potential treatment for dehydroepiandrosterone-induced polycystic ovary syndrome in the rat.
Topics: Adiponectin; Animals; Aromatase; Dehydroepiandrosterone; Disease Models, Animal; Estradiol; Female; Nucleobindins; Ovary; Phytoestrogens; Polycystic Ovary Syndrome; Quercetin; Rats, Sprague-Dawley; Receptors, Adiponectin; Uterus | 2020 |
Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Topics: Adjuvants, Immunologic; Animals; Antioxidants; Dehydroepiandrosterone; Disease Models, Animal; Female; Gene Expression Regulation; Granulosa Cells; Ovary; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-bcl-2; Quercetin; Rats; Rats, Wistar; Receptors, Androgen; RNA, Messenger | 2020 |
Amelioration of oxidative stress-mediated apoptosis in copper oxide nanoparticles-induced liver injury in rats by potent antioxidants.
Topics: Animals; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury; Dehydroepiandrosterone; DNA Damage; DNA Fragmentation; Drug Therapy, Combination; Liver; Male; Nanoparticles; Oxidative Stress; Oxidoreductases; Proto-Oncogene Proteins c-bcl-2; Quercetin; Rats, Wistar | 2020 |
Mechanism of quercetin on the improvement of ovulation disorder and regulation of ovarian CNP/NPR2 in PCOS model rats.
Topics: Animals; bcl-2-Associated X Protein; Dehydroepiandrosterone; Female; Follicle Stimulating Hormone; Humans; Interleukin-6; Luteinizing Hormone; Natriuretic Peptide, C-Type; Ovulation; Polycystic Ovary Syndrome; Quercetin; Rats; Receptors, Atrial Natriuretic Factor; Tumor Necrosis Factor-alpha | 2022 |
The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Topics: Androgen Antagonists; Animals; Dehydroepiandrosterone; Disease Models, Animal; Female; Hyperandrogenism; Ovary; Polycystic Ovary Syndrome; Quercetin; Rats; Rats, Wistar | 2022 |
Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Glucosephosphate Dehydrogenase; High-Throughput Screening Assays; Humans; NADP; Ovarian Neoplasms; Oxidation-Reduction; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance | 2021 |